Cervical cancer detection assay, 5/15

May 2015—Enzo Biochem announced the development of the FlowScript assay in detection of messenger RNA from HPV oncogenes E6 and E7. The FlowScript technology platform is a proprietary flow-cytometry-based molecular detection system for the multiplex analysis of cell function and identity; the HPV E6/E7 assay is the first product to use this novel platform. Analysis is performed on a small volume of a liquid cytology specimen and can be incorporated as a reflex test measure following abnormal Pap smear results.

The assay, and the platform on which it is based, allows for the simultaneous analysis of several different genes expressed in every cell in a given sample, making it possible to produce clinically relevant data at the single cell level. Additionally, the assay’s use of external control improves run-to-run consistency, reducing hands-on time. The company anticipates applying this platform to, for example, the study of other cancers, immune-related disorders, and drug development.

Enzo Biochem, 212-583-0100